IDAMYCIN Side Effects

6644807-9 | Vasculitis
on Mar 10, 2010 Male patient from JAPAN , 35 years of age, was treated with Idamycin (View Usage). Patient experienced the following unwanted or unexpected effects: vasculitis (What is vasculitis?). Idamycin dosage: Unk.

6505890-4 | Cytomegalovirus Chorioretinitis, Oral Candidiasis
Patient was taking Idamycin (View Usage). Patient had the following side effects: cytomegalovirus chorioretinitis, oral candidiasis on Dec 08, 2009 from JAPAN Additional patient health information: Male patient , child 7 years of age, was diagnosed with acute myeloid leukaemia and. Idamycin dosage: 10 Mg/m2. During the same period patient was treated with CYTARABINE (18 G/m2) (View Cytarabine Review and Cytarabine Label ).

6499105-3 | Febrile Neutropenia
Adverse event was reported on Dec 03, 2009 by a Male patient taking Idamycin (View Usage) (Dosage: Inj) was diagnosed with acute myeloid leukaemia and. Location: JAPAN , child 9 years of age, After Idamycin was administered, patient had the following side effects: febrile neutropenia. During the same period patient was treated with CYLOCIDE (Inj) (View Cylocide Review and Cylocide Label ), FLUDARABINE (View Fludarabine Review and Fludarabine Label ).

6499098-9 | Febrile Neutropenia
on Dec 03, 2009 Female patient from JAPAN , child 5 years of age, was diagnosed with acute myeloid leukaemia and was treated with Idamycin (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia. Idamycin dosage: Inj.


6231719-8 | Febrile Neutropenia
on Jun 08, 2009 Female patient from JAPAN , 60 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Idamycin (View Usage). Patient had the following side effects: febrile neutropenia. Idamycin dosage: Unk. During the same period patient was treated with CYLOCIDE (140 Mg, 1x/day) (View Cylocide Review and Cylocide Label ), VESANOID (3x/day (30mg-20mg-30mg)) (View Vesanoid Review and Vesanoid Label ).

6210793-9 | Febrile Neutropenia, Necrotising Fasciitis
Patient was taking Idamycin (View Usage). After Idamycin was administered, patient had the following side effects: febrile neutropenia, necrotising fasciitis on May 20, 2009 from JAPAN Additional patient health information: Female patient , 60 years of age, was diagnosed with acute promyelocytic leukaemia and. Idamycin dosage: . During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), VESANOID (View Vesanoid Review and Vesanoid Label ).

6179135-1 | Contusion, Febrile Neutropenia, Infusion Site Infection, Myelodysplastic Syndrome
Adverse event was reported on Apr 27, 2009 by a Female patient taking Idamycin (View Usage) (Dosage: Once) was diagnosed with myelodysplastic syndrome, multiple sclerosis (What is multiple sclerosis?), fatigue, sleep disorder (What is sleep disorder?), depression (What is depression?) and. Location: UNITED STATES , weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: contusion, febrile neutropenia, infusion site infection, myelodysplastic syndrome. During the same period patient was treated with CYTOSAR U (Once) (View Cytosar-u Review and Cytosar-u Label ), REBIF (8.8 Ug, 3 In 1 Weeks) (View Rebif Review and Rebif Label ), PROVIGIL (Unk) (View Provigil Review and Provigil Label ), CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label ), PROZAC (Unk) (View Prozac Review and Prozac Label ). Patient was hospitalized.

6170392-4 | Contusion, Febrile Neutropenia, Infusion Site Infection, Myelodysplastic Syndrome
on Apr 16, 2009 Female patient from UNITED STATES , weighting 136.7 lb, was diagnosed with myelodysplastic syndrome, multiple sclerosis (What is multiple sclerosis?), fatigue, sleep disorder (What is sleep disorder?), depression (What is depression?) and was treated with Idamycin (View Usage). Patient had the following side effects: contusion, febrile neutropenia, infusion site infection, myelodysplastic syndrome. Idamycin dosage: Once. During the same period patient was treated with CYTOSAR U (Once) (View Cytosar-u Review and Cytosar-u Label ), REBIF (8.8 Ug, 3 In 1 Weeks) (View Rebif Review and Rebif Label ), PROVIGIL (Unk) (View Provigil Review and Provigil Label ), CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label ), PROZAC (Unk) (View Prozac Review and Prozac Label ). Patient was hospitalized.

6126481-3 | Contusion, Febrile Neutropenia, Infusion Site Infection, Myelodysplastic Syndrome
on Mar 10, 2009 Female patient from UNITED STATES , weighting 136.7 lb, was diagnosed with myelodysplastic syndrome, multiple sclerosis (What is multiple sclerosis?), fatigue, sleep disorder (What is sleep disorder?), depression (What is depression?) and was treated with Idamycin (View Usage). After Idamycin was administered, patient had the following side effects: contusion, febrile neutropenia, infusion site infection, myelodysplastic syndrome. Idamycin dosage: Once. During the same period patient was treated with CYTOSAR U (Once) (View Cytosar-u Review and Cytosar-u Label ), REBIF (8.8 Ug, 3 In 1 Weeks) (View Rebif Review and Rebif Label ), PROVIGIL (Unk) (View Provigil Review and Provigil Label ), CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label ), PROZAC (Unk) (View Prozac Review and Prozac Label ). Patient was hospitalized.

6085570-2 | Cardiac Failure, Cardiotoxicity, Hypercalcaemia, Palpitations, Thirst, Vomiting
Patient was taking Idamycin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, cardiotoxicity, hypercalcaemia, palpitations, thirst, vomiting on Feb 06, 2009 from JAPAN Additional patient health information: Female patient , 21 years of age, was diagnosed with acute promyelocytic leukaemia and. Idamycin dosage: . During the same period patient was treated with DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), RETINOIC ACID (View Retinoic Acid Review and Retinoic Acid Label ).

5938036-1 | Cardiac Failure, Hypercalcaemia, Thirst, Vomiting
Adverse event was reported on Oct 21, 2008 by a Female patient taking Idamycin (View Usage) (Dosage: Daily Dose:12mg/m2) was diagnosed with acute promyelocytic leukaemia and. Location: JAPAN , 21 years of age, Patient had the following side effects: cardiac failure, hypercalcaemia, thirst, vomiting. During the same period patient was treated with DAUNORUBICIN HCL (Daily Dose:50mg/m2) (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), CYTARABINE (Daily Dose:100mg/m2) (View Cytarabine Review and Cytarabine Label ), MITOXANTRONE (Daily Dose:7mg/m2) (View Mitoxantrone Review and Mitoxantrone Label ), RETINOIC ACID (Daily Dose:45mg/m2) (View Retinoic Acid Review and Retinoic Acid Label ).

5924220-X | Cardiac Failure, Hypercalcaemia, Thirst, Vomiting
on Oct 08, 2008 Female patient from JAPAN , 21 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Idamycin (View Usage). After Idamycin was administered, patient had the following side effects: cardiac failure, hypercalcaemia, thirst, vomiting. Idamycin dosage: Daily Dose:12mg/m2. During the same period patient was treated with DAUNORUBICIN HCL (Daily Dose:50mg/m2) (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), CYTARABINE (Daily Dose:100mg/m2) (View Cytarabine Review and Cytarabine Label ), MITOXANTRONE (Daily Dose:7mg/m2) (View Mitoxantrone Review and Mitoxantrone Label ), RETINOIC ACID (Daily Dose:45mg/m2) (View Retinoic Acid Review and Retinoic Acid Label ).

5832860-1 | Hypercalcaemia
on Jul 23, 2008 Male patient from JAPAN , 24 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Idamycin (View Usage). Patient experienced the following unwanted or unexpected effects: hypercalcaemia. Idamycin dosage: Daily Dose:12mg/m2. During the same period patient was treated with PRODIF (Daily Dose:504.5mg) (View Prodif Review and Prodif Label ), TRETINOIN (View Tretinoin Review and Tretinoin Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), GRANULOCYTE MACROPHAGE COLONY STIM FACTOR (View Granulocyte Macrophage Colony Stim Factor Review and Granulocyte Macrophage Colony Stim Factor Label ).

5710307-3 | Blood Creatine Phosphokinase Increased, Cardiovascular Disorder, Face Oedema, Oedema Peripheral
Patient was taking Idamycin (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, cardiovascular disorder, face oedema, oedema peripheral on Apr 07, 2008 from JAPAN Additional patient health information: Male patient , 61 years of age, was diagnosed with chronic myeloid leukaemia and. Idamycin dosage: Daily Dose:19mg. During the same period patient was treated with CYLOCIDE (View Cylocide Review and Cylocide Label ).

5700519-7 | Blood Creatine Phosphokinase Increased, Cardiovascular Disorder, Face Oedema, Oedema Peripheral
Adverse event was reported on Mar 28, 2008 by a Male patient taking Idamycin (View Usage) (Dosage: Daily Dose:19mg) . Location: JAPAN , 61 years of age, After Idamycin was administered, patient had the following side effects: blood creatine phosphokinase increased, cardiovascular disorder, face oedema, oedema peripheral. During the same period patient was treated with CYLOCIDE (View Cylocide Review and Cylocide Label ).

5430030-2 | Blood Bilirubin Increased
on Aug 17, 2007 Male patient from JAPAN , 50 years of age, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Idamycin (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased. Idamycin dosage: Daily Dose:18mg. During the same period patient was treated with VFEND (Daily Dose:400mg) (View Vfend Review and Vfend Label ), MAXIPIME (Daily Dose:2gram) (View Maxipime Review and Maxipime Label ), CYLOCIDE (Daily Dose:150mg) (View Cylocide Review and Cylocide Label ), POLYMYXIN B SULFATE (View Polymyxin B Sulfate Review and Polymyxin B Sulfate Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), ZANTAC 150 (View Zantac 150 Review and Zantac 150 Label ), ISODINE (View Isodine Review and Isodine Label ), BIAPENEM (View Biapenem Review and Biapenem Label ). Patient was hospitalized.

5424207-X | Blood Bilirubin Increased
on Aug 13, 2007 Male patient from JAPAN , 58 years of age, was treated with Idamycin (View Usage). Patient had the following side effects: blood bilirubin increased. Idamycin dosage: Text:tdd:18 Mg. During the same period patient was treated with CYLOCIDE (View Cylocide Review and Cylocide Label ), POLYMYXIN B SULFATE (View Polymyxin B Sulfate Review and Polymyxin B Sulfate Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), ZANTAC 150 (View Zantac 150 Review and Zantac 150 Label ), ISODINE (View Isodine Review and Isodine Label ).

5189923-6 | Interstitial Lung Disease
Patient was taking Idamycin (View Usage). After Idamycin was administered, patient had the following side effects: interstitial lung disease on Dec 04, 2006 from JAPAN Additional patient health information: Male patient , 76 years of age, . Idamycin dosage: 12 Mg, Intravenous. During the same period patient was treated with SUNRABIN (ENOCITABINE) (View Sunrabin (enocitabine) Review and Sunrabin (enocitabine) Label ).

5186336-8 | Acute Lymphocytic Leukaemia, White Blood Cell Count Increased
Adverse event was reported on Nov 30, 2006 by a Male patient taking Idamycin (View Usage) (Dosage: 23 Mg (frequency: Qd), Intravenous) was diagnosed with acute myeloid leukaemia and. Location: JAPAN , 53 years of age, weighting 215.2 lb, Patient experienced the following unwanted or unexpected effects: acute lymphocytic leukaemia, white blood cell count increased. During the same period patient was treated with CYTARABINE (380 Mg (frequency: Qd), Intravenous) (View Cytarabine Review and Cytarabine Label ), MITOXANTRONE (14 Mg (qd), Intravenous) (View Mitoxantrone Review and Mitoxantrone Label ), DAUNORUBICIN HCL (100 Mg (qd), Intravenous) (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ACLACINON (ACLARUBICIN HYDROCHLORIDE) (30 Mg (qd), Intravenous) (View Aclacinon (aclarubicin Hydrochloride) Review and Aclacinon (aclarubicin Hydrochloride) Label ), ETOPOSIDE (180 Mg (qd), Intravenous) (View Etoposide Review and Etoposide Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), ANTIBIOTICS (ANTIBIOTICS) (View Antibiotics (antibiotics) Review and Antibiotics (antibiotics) Label ). Patient was hospitalized.

5099629-X | Acute Myeloid Leukaemia Recurrent, Histiocytosis Haematophagic
on Aug 21, 2006 Female patient from JAPAN , 20 years of age, was diagnosed with acute myeloid leukaemia and was treated with Idamycin (View Usage). Patient had the following side effects: acute myeloid leukaemia recurrent, histiocytosis haematophagic. Idamycin dosage: 18 Mg (1 In 1 D), Intravenous. During the same period patient was treated with CYTARABINE (210 Mg (1 In 1 D), Intravenous) (View Cytarabine Review and Cytarabine Label ).

5093068-3 | Aplastic Anaemia, Histiocytosis Haematophagic
on Aug 14, 2006 Female patient from JAPAN , 20 years of age, was diagnosed with acute myeloid leukaemia and was treated with Idamycin (View Usage). After Idamycin was administered, patient had the following side effects: aplastic anaemia, histiocytosis haematophagic. Idamycin dosage: 18 Mg (1 In 1 D), Intravenous. During the same period patient was treated with CYTARABINE (210 Mg (1 In 1 D), Intravenous) (View Cytarabine Review and Cytarabine Label ).

4788813-8 | Aspergilloma, Dyspnoea, Haemorrhage, Hypoxia, Infection, Leukopenia, Obstructive Airways Disorder, Respiratory Arrest
Patient was taking Idamycin (View Usage). Patient experienced the following unwanted or unexpected effects: aspergilloma, dyspnoea, haemorrhage, hypoxia, infection (What is infection?), leukopenia, obstructive airways disorder, respiratory arrest on Sep 21, 2005 from JAPAN Additional patient health information: Female patient , 49 years of age, was diagnosed with acute myeloid leukaemia and. Idamycin dosage: Intravenous. During the same period patient was treated with CYTARABINE (Intravenous) (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN (DAUNORUBICIN) (View Daunorubicin (daunorubicin) Review and Daunorubicin (daunorubicin) Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MICAFUNGIN (MICAFUNGIN) (View Micafungin (micafungin) Review and Micafungin (micafungin) Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ).

4785389-6 | Aspergilloma, Haemorrhage, Hypoxia, Infection, Leukopenia, Obstructive Airways Disorder, Respiratory Arrest
Adverse event was reported on Sep 14, 2005 by a Female patient taking Idamycin (View Usage) (Dosage: Intravenous) was diagnosed with acute myeloid leukaemia and. Location: JAPAN , 49 years of age, Patient had the following side effects: aspergilloma, haemorrhage, hypoxia, infection (What is infection?), leukopenia, obstructive airways disorder, respiratory arrest. During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN (DAUNORUBICIN) (View Daunorubicin (daunorubicin) Review and Daunorubicin (daunorubicin) Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MICAFUNGIN (MICAFUNGIN) (View Micafungin (micafungin) Review and Micafungin (micafungin) Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ).

4781444-5 | Aspergilloma, Dyspnoea, Foreign Body Trauma, Haemorrhage, Hypoxia, Infection, Leukopenia, Obstructive Airways Disorder
on Sep 14, 2005 Female patient from JAPAN , 49 years of age, was diagnosed with acute myeloid leukaemia and was treated with Idamycin (View Usage). After Idamycin was administered, patient had the following side effects: aspergilloma, dyspnoea, foreign body trauma, haemorrhage, hypoxia, infection (What is infection?), leukopenia, obstructive airways disorder. Idamycin dosage: Intravenous. During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN (DAUNORUBICIN) (View Daunorubicin (daunorubicin) Review and Daunorubicin (daunorubicin) Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MICAFUNGIN (MICAFUNGIN) (View Micafungin (micafungin) Review and Micafungin (micafungin) Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ).

4634893-X | Aplasia, Eosinophil Percentage Increased, Hypotension, Lung Neoplasm, Lymphocyte Count Increased, Pruritus, Pyrexia, Rash Maculo-papular, Respiratory Distress
on Mar 30, 2005 Male patient from , 29 years of age, was diagnosed with acute myeloid leukaemia and was treated with Idamycin (View Usage). Patient experienced the following unwanted or unexpected effects: aplasia, eosinophil percentage increased, hypotension, lung neoplasm, lymphocyte count increased, pruritus, pyrexia, rash maculo-papular, respiratory distress. Idamycin dosage: (10 Mg), Intravenous.